| • |
The company used CRFs expertise in the area of Parenteral Fat Emulsions (Lipid Drug Delivery Systems) to manufacture Propofol.
|
| • |
CRF has developed expertise in Liposomal Drug Delivery Systems (LDDS). There are several drugs in the pipeline, which have reached a threshold for the next stage in development.
|
| • |
The foundation has initiated its research program in the field of Biotechnology with a focus on R&D of Monoclonal Antibodies and Recombinant Technology.
|
|
| • |
Development of products like TNA/TNA-Peri/PNA (triple /double chamber nutrition system), Glutammune (l-glutamine), TetraHES (tetrastarch), Sufentil (sufentanil citrate Inj.) are significant breakthroughs for CRF.
|
| • |
A proprietary multi-layer film has been developed for bag manufacturing.
|
| • |
Specific bulk drugs development (API) like Hydroxyethyl starch, Iron sucrose, and Pamidronic Acid makes Claris one of the few manufacturers of such drugs in the world.
|
|
